TISSUE & FFPE COHORT COLLECTIONS
Lung cancer tissue microarrays & FFPE blocks
Explore NSCLC and SCLC arrays by histology, molecular profile and treatment context. Compare adenocarcinoma and squamous cell carcinoma collections, matched tissue, and selected clinical or molecular datasets. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Lung cancer arrays (53)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
IO Multi tumor array 1 of a set of 6 TMAs : Breast cancer ER+, Her2+, TNBC, NSCLC(SCC), NSCLC(ADC), Small Cell Lung Cancer (SCLC) with histopath data, 1x1mm core each from tumor & invasive edge (TA3124)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 1 of a set of 6 TMAs : Breast cancer ER+, Her2+, TNBC, NSCLC(SCC), NSCLC(ADC), Small Cell Lung Cancer (SCLC) with histopath data, 1x1mm core each from tumor & invasive edge (TA4439)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Metastatic Melanoma & NSCLC with 2nd line IO treatment follow up information (TA3088)
- Approx. cores
- 55
- Approx. donors
- 55
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Multi tumor array 1 of a set of 4 TMAs : Breast cancer ER+, Her2+, TNBC, CRC, NSCLC, Prostate ADC with histopath data (TA2995)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array 3 of a set of 4 TMAs : Small Cell Lung Cancer (SCLC), HD, HCC, RCC, GBM, GEJ, Cervical with histopath data (TA2997)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from NSCLC, Bladder(UC), Ovarian, Gastric & RCC. TMA1 of a set of 2 TMAs, histopath data (TA4312)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4321)
- Approx. cores
- 124
- Approx. donors
- 64
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4331)
- Approx. cores
- 110
- Approx. donors
- 69
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4341)
- Approx. cores
- 45
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Normal (non-malignant) breast, colon, lymph node, lung, prostate & breast cancer, CRC, prostate ADC, NSCLC & DLBCL, 2mm (TA2942)
- Approx. cores
- 30
- Approx. donors
- 30
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC (ADC & SCC) primary & matched nodal mets (TA4493)
- Approx. cores
- 123
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (ADC & SCC) stages IIIA, IIIB & IV with histopath and optional PD-L1 (22C3) IHC data (TA4305)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Optional datasets listed; review coverage
NSCLC (ADC & SCC) stages IIIB & IV with histopath and optional follow up & PD-L1 (22C3) IHC data (same as TA4307) (TA4448)
- Approx. cores
- 80
- Approx. donors
- 80
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Optional datasets listed; review coverage
NSCLC (ADC & SCC) stages IIIB & IV with histopath and optional follow up & PD-L1 (22C3) IHC data (TA4307)
- Approx. cores
- 80
- Approx. donors
- 80
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Optional datasets listed; review coverage
NSCLC (ADC & SCC) with follow up & PD-L1(22C3) IHC data (TA4311)
- Approx. cores
- 126
- Approx. donors
- 126
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (ADC & SCC) with histopath data, PD-L1(22C3) status & Oncomine Precision Assay NGS data – optional follow up data (TA4327)
- Approx. cores
- 106
- Approx. donors
- 106
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (ADC & SCC) with low, moderate & high PD-L1(22C3) expression with histopath data – optional follow up data (TA4333)
- Approx. cores
- 36
- Approx. donors
- 36
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (ADC) with follow up, PD-L1(22C3) & MSI data (new version of TA2855) (TA4444)
- Approx. cores
- 93
- Approx. donors
- 93
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (ADC) with follow up, PD-L1(22C3) & MSI data (TA2855)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (EGFR mutated & wild type) with histopath data (new version of TA4322) (TA4479)
- Approx. cores
- 44
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (EGFR mutated & wild type) with histopath data (TA4322)
- Approx. cores
- 44
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (KRAS mutated & wild type) with histopath data (TA4323)
- Approx. cores
- 54
- Approx. donors
- 54
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (PD-L1) (TA3162)
- Approx. cores
- 140
- Approx. donors
- 140
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC (SCC) with histopath data (Same as TA3112) (TA4456)
- Approx. cores
- 65
- Approx. donors
- 65
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC (SCC) with histopath data (TA3112)
- Approx. cores
- 65
- Approx. donors
- 65
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC ADC (III_IV) with follow up data TMA (TA4413)
- Approx. cores
- 48
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
NSCLC ADC & SCC Stage III_IV with follow up data (LDS) – 30 ADC & 15 SCC, 40 Stage IIIA & IIIB, 5 Stage IV, 2 × 1 mm cores per donor, and 2 replicates (TA4490)
- Approx. cores
- 90
- Approx. donors
- 45
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
NSCLC ADC III_IV (TA4492)
- Approx. cores
- 49
- Approx. donors
- 49
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC array with histopath data & matched plasma (TA4458)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC donor matched pre & post treatment samples with follow up data (Same as TA3111) (TA4437)
- Approx. cores
- 28
- Approx. donors
- 14
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC post-treatment samples with follow up, KRAS & EGFR mutation data (new version of TA3150) (TA4480)
- Approx. cores
- 46
- Approx. donors
- 23
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC post-treatment samples with follow up, KRAS & EGFR mutation data (TA3150)
- Approx. cores
- 50
- Approx. donors
- 25
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC primary & matched nodal mets with histopath data (TA4303)
- Approx. cores
- 66
- Approx. donors
- 33
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC SCC TMA (III & IV) – histopath data (TA4484)
- Approx. cores
- 48
- Approx. donors
- 48
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC TMA with EGFR mutations (TA2826)
- Approx. cores
- 27
- Approx. donors
- 27
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC TMA with EGFR mutations & follow up data (new version of TA2826) (TA4488)
- Approx. cores
- 48
- Approx. donors
- 48
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC TMA with IO follow up data (New version of TA4301) (TA4387)
- Approx. cores
- 40
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC TMA with KRAS mutations (TA2820)
- Approx. cores
- 48
- Approx. donors
- 48
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC TMA with TKI responders/non responders & follow up data (TA4397)
- Approx. cores
- 44
- Approx. donors
- 22
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC with 2nd line IO follow up & optional RNAseq, GeoMx (protein & RNA panels), DAB IHC data (TA4301)
- Approx. cores
- 42
- Approx. donors
- 42
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Optional datasets listed; review coverage
NSCLC with 2nd line IO follow up data (TA4412)
- Approx. cores
- 67
- Approx. donors
- 31
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC with KRAS & EGFR mutation data TMA (TA2907)
- Approx. cores
- 45
- Approx. donors
- 45
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
NSCLC with SOC chemo follow up & optional GeoMx (protein panel) data (same as TA4302) (TA4447)
- Approx. cores
- 48
- Approx. donors
- 48
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Optional datasets listed; review coverage
RNAscope pre-qualified Lung cancer TMA (Small Cell Lung Cancer (SCLC), NSCLC (ADC), NSCLC (SCC), histopath data, sub-set with EGFR mutation status (TA3168)
- Approx. cores
- 56
- Approx. donors
- 56
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
RNAscope pre-qualified Lung cancer TMA (Small Cell Lung Cancer (SCLC), NSCLC (ADC), NSCLC (SCC), histopath data, sub-set with EGFR mutation status (TA4394)
- Approx. cores
- 56
- Approx. donors
- 56
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
RNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA1 of a set of 2 TMAs, histopath data (TA3117)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Small Cell Lung Cancer (SCLC) TMA with follow up data (new version of TA4433) (TA4501)
- Approx. cores
- 47
- Approx. donors
- 47
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Small Cell Lung Cancer (SCLC) TMA with follow up data (TA4433)
- Approx. cores
- 50
- Approx. donors
- 50
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Small Cell Lung Cancer (SCLC) with follow up data (TA2893)
- Approx. cores
- 25
- Approx. donors
- 25
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Small Cell Lung Cancer (SCLC) with follow up data (TA4408)
- Approx. cores
- 30
- Approx. donors
- 15
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, breast cancer, NSCLC, HD (TA3108)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Lung cancer FFPE blocks for your study
NSCLC cohorts with histopathology, EGFR/KRAS, PD-L1, treatment, matching or optional datasets.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Lung cancer FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #111
NSCLC (ADC & SCC) primary & matched nodal mets
Cohort #112
NSCLC (ADC & SCC) stage III/IV with follow up data
Cohort #113
NSCLC (ADC & SCC) stages IIIA, IIIB & IV with histopath data
Cohort #115
NSCLC (ADC & SCC) with follow up data
Cohort #117
NSCLC (ADC & SCC) with low, moderate & high PD-L1(22C3) expression with histopath data - optional follow up data
Cohort #118
NSCLC (ADC) with follow up, PD-L1(22C3) & MSI data
Cohort #119
NSCLC (EGFR mutated & wild type) with histopath data
Cohort #120
NSCLC (KRAS mutated & wild type) with histopath data
Cohort #121
NSCLC with histopath data & (PD-L1) scores 22C3
Cohort #122
NSCLC (SCC) with histopath data
Cohort #127
NSCLC post-treatment samples with follow up, KRAS & EGFR mutation data
Cohort #128
NSCLC primary & matched nodal mets with histopath data
Cohort #131
NSCLC with EGFR mutations & histopath data
Cohort #132
NSCLC with EGFR mutations & follow up data
Cohort #134
NSCLC with KRAS & EGFR mutation data
Cohort #135
NSCLC with KRAS mutations status
Cohort #136
NSCLC with SOC chemo follow up & optional GeoMx (protein panel) data
Cohort #137
NSCLC with TKI responders/non responders & follow up data
Cohort #138
NSCLC with histopath data & matched plasma
NSCLC · Patient profile
EGFR-mutated locally advanced or metastatic disease
NSCLC · Patient profile
EGFR-mutated, MET-positive locally advanced or metastatic disease
NSCLC · Patient profile
EGFR exon 20 insertion mutation
NSCLC · Patient profile
TKI-treatment-naïve ROS1-positive disease
NSCLC · Patient profile
Advanced or metastatic NSCLC
NSCLC · Patient profile
PD-L1 <50% metastatic NSCLC
NSCLC · Patient profile
PD-L1 tumor-cell expression ≥1% non-squamous NSCLC
NSCLC · Patient profile
PD-L1 tumor-cell expression ≥1% squamous NSCLC
NSCLC · Patient profile
PD-L1 tumor-cell expression ≥50% locally advanced or metastatic non-squamous NSCLC
NSCLC · Patient profile
Before or after immunotherapy / checkpoint inhibitor treatment
Small-cell lung cancer · Patient profile
Relapsed / refractory small-cell lung cancer
Small-cell lung cancer · Patient profile
Extensive-stage small-cell lung cancer
SELECTING YOUR ARRAY
Match lung histology, markers and treatment context
A marker-defined array and a treatment-follow-up array answer different selection needs. Review the tissue and the associated records together.























